| (Values in U.S. Thousands) | Nov, 2024 | Nov, 2023 | Nov, 2022 | Nov, 2021 | Nov, 2020 |
| Sales | 623 | 321 | 14 | 0 | 0 |
| Sales Growth | +94.07% | +2,149.52% | unch | unch | unch |
| Net Income | -4,260 | -3,433 | -4,296 | -4,498 | -2,073 |
| Net Income Growth | -24.07% | +20.07% | +4.50% | -117.00% | -492.02% |
Psyched Wellness Ltd (PSYC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Psyched Wellness Ltd is a Canada-based health supplements company, which is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company is producing and developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives, such as promote stress relief, relaxation, and assist with restful sleeping. The Company's subsidiaries include Psyched Wellness Corp., and AME Wellness Inc.
Fiscal Year End Date: 11/30